|
2024
|
G/S
|
Pharmaceutical preparations for the treatment of the intestinal tract including the esophagus |
|
|
G/S
|
Pharmaceutical preparations for the treatment of the intestinal tract and the liver |
|
2023
|
G/S
|
Pharmaceutical preparations. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of metabolic diseases and diseases of the digestive... |
|
|
Invention
|
Anti-cd30l antibodies, formulations therefor, and uses thereof. Described herein are anti-CD30L a... |
|
|
Invention
|
Pharmaceutical formulation for the treatment of inflammatory changes to the rectum.
Disclosed is... |
|
2022
|
Invention
|
Oral formulation of a pyridinone derivate and use thereof in prophylaxis and/or treatment of inte... |
|
|
Invention
|
Anti-cd30l antibodies and uses thereof. Described herein are anti-CD30L antibodies and pharmaceut... |
|
|
Invention
|
Pharmaceutical composition for the oral administration of poorly soluble drugs comprising an amor... |
|
|
Invention
|
Orodispersible effervescent tablet comprising budesonide for use in the treatment of eosinophilic... |
|
|
Invention
|
Anti-cd30l antibodies and uses thereof.
Described herein are anti-CD30L antibodies and pharmaceu... |
|
|
Invention
|
Enema for rectal application. Provided is an enema for rectal application containing budesonide a... |
|
2021
|
G/S
|
Pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune disease... |
|
|
G/S
|
Pharmaceutical preparations, namely for the domains of gastroenterology and hepatology. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseas... |
|
|
G/S
|
Pharmaceuticals. |
|
|
Invention
|
Systemic formulation of a pyridinone derivate for tg2-related diseases.
The present invention re... |
|
|
Invention
|
Systemic formulation of a pyridinone derivate for coeliac disease.
The present invention relates... |
|
|
Invention
|
Systemic formulation of a pyridinone derivate for tg2-related diseases. The present invention rel... |
|
|
Invention
|
Systemic formulation of a pyridinone derivate for coeliac disease. The present invention relates ... |
|
2020
|
Invention
|
Pharmaceutical formulation for the treatment of inflammatory changes to the rectum. Disclosed is ... |
|
|
Invention
|
Optimized pharmaceutical formulation for the treatment of inflammatory conditions of the esophagu... |
|
2019
|
Invention
|
Pellets having a multi-layer structure for delayed release of the active substance in the distal ... |
|
|
Invention
|
Methods and systems for selection and treatment of patients with inflammatory diseases.
Describe... |
|
|
Invention
|
Methods and systems for selection and treatment of patients with inflammatory diseases. Described... |
|
2018
|
Invention
|
Use of nor-ursodeoxycholic acid for reducing liver fat. The present invention relates to the use ... |
|
2017
|
G/S
|
Intestinal disorder medicine for the treatment of ulcerative colitis. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of inflammation of the upper gastrointestinal tract |
|
2016
|
Invention
|
Optimized synthesis of pure, non-polymorphic, crystalline bile acids with defined particle size. ... |
|
|
Invention
|
Optimized high-dose mesalazine-containing tablet. The present invention relates to an oral enteri... |
|
|
Invention
|
Optimized high-dose mesalazine-containing tablet. The invention relates to an oral gastric-juice ... |
|
|
Invention
|
Optimised high-dose mesalazine-containing tablet. The invention relates to an oral gastric-juice ... |
|
|
Invention
|
Pharmaceutical formulation for the treatment of inflammatory changes to the rectum. The invention... |
|
2015
|
Invention
|
Enema for rectal application.
Provided is an enema for rectal application containing budesonide ... |
|
|
Invention
|
Enema for rectal application. Provided is an enema for rectal application, which can be used for ... |
|
|
G/S
|
Pharmaceutical preparations, other than prophylaxis for
transplant rejections, uveitis, psoriasi... |
|
2014
|
Invention
|
Pellet formulation for the treatment of the intestinal tract.
An orally administrable pharmaceut... |
|
|
Invention
|
Method of treating ulcerative colitis.
Provided herein are methods of treating and inducing ulce... |
|
|
Invention
|
Method for treating ulcerative colitis.
Provided herein are methods of treating and inducing ulc... |
|
|
Invention
|
Methods of treating ulcerative colitis.
Provided herein are methods of treating and inducing ulc... |
